CGS-authored
LOS ANGELES - Robert Klein II, the campaign chairman who became the head of the state's stem cell agency's board, should step down from that job because of his failed leadership, the Center for Genetics and Society said Wednesday.
The organization, which supports stem cell research but has frequently criticized the state's stem cell program, issued a report card Wednesday giving a grade of C- for a "very disappointing" first full year of operation of the research agency created by Proposition 71 in November 2004.
The Oakland-based nonprofit organization singled out Klein for criticism, saying he'd run the agency like a private venture and continued to hype Proposition 71 as chairman of the stem cell agency's oversight board.
"It is Bob Klein's pattern of ineffective Leadership and irresponsibility toward the public's interest that has prompted us to make this call," said Marcy Darnovsky, the center's associate executive director. "He has adopted what really amounts to a hostile attitude to many elected officials in the state, and he's really operated (the California Institute for Regenerative Medicine) like a private enterprise instead...
The organization, which supports stem cell research but has frequently criticized the state's stem cell program, issued a report card Wednesday giving a grade of C- for a "very disappointing" first full year of operation of the research agency created by Proposition 71 in November 2004.
The Oakland-based nonprofit organization singled out Klein for criticism, saying he'd run the agency like a private venture and continued to hype Proposition 71 as chairman of the stem cell agency's oversight board.
"It is Bob Klein's pattern of ineffective Leadership and irresponsibility toward the public's interest that has prompted us to make this call," said Marcy Darnovsky, the center's associate executive director. "He has adopted what really amounts to a hostile attitude to many elected officials in the state, and he's really operated (the California Institute for Regenerative Medicine) like a private enterprise instead...